Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Fitzal

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 25, 2005
Effect of laser perforation on the remodeling of acellular matrix graftsHelga Bergmeister, Peter Boeck, Marie-Theres Kasimir, et al.
Annals of Surgical Oncology|December 31, 2011
Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)Christoph Tausch, Susanne Taucher, Peter Dubsky, et al.
The EPMA Journal|February 24, 2025
Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in AustriaMichael Bolliger, Daniel Wasinger, Julia Brunmair, et al.
Investigative Radiology|August 5, 2009
A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial resultsKatja Pinker, Gunther Grabner, Wolfgang Bogner, et al.
Annals of Surgery|May 15, 2019
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE TrialFlorian Fitzal, Vesna Bjelic-Radisic, Michael Knauer, et al.
Breast Cancer Research and Treatment|April 10, 2007
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patientsFlorian Fitzal, Otto Riedl, Lisa Wutzl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast CancerIvana Sestak, Martin Filipits, Richard Buus, et al.
Clinical Breast Cancer|June 30, 2009
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?Michael Gnant, Peter Dubsky, Florian Fitzal, et al.
Oncoimmunology|November 29, 2023
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancerMaximilian Marhold, Simon Udovica, Anna Halstead, et al.
Cancer|December 12, 2003
Do we need HER-2/neu testing for all patients with primary breast carcinoma?Susanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 25, 2005
Effect of laser perforation on the remodeling of acellular matrix graftsHelga Bergmeister, Peter Boeck, Marie-Theres Kasimir, et al.
Annals of Surgical Oncology|December 31, 2011
Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)Christoph Tausch, Susanne Taucher, Peter Dubsky, et al.
The EPMA Journal|February 24, 2025
Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in AustriaMichael Bolliger, Daniel Wasinger, Julia Brunmair, et al.
Investigative Radiology|August 5, 2009
A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial resultsKatja Pinker, Gunther Grabner, Wolfgang Bogner, et al.
Annals of Surgery|May 15, 2019
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE TrialFlorian Fitzal, Vesna Bjelic-Radisic, Michael Knauer, et al.
Breast Cancer Research and Treatment|April 10, 2007
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patientsFlorian Fitzal, Otto Riedl, Lisa Wutzl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2020
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast CancerIvana Sestak, Martin Filipits, Richard Buus, et al.
Clinical Breast Cancer|June 30, 2009
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?Michael Gnant, Peter Dubsky, Florian Fitzal, et al.
Oncoimmunology|November 29, 2023
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancerMaximilian Marhold, Simon Udovica, Anna Halstead, et al.
Cancer|December 12, 2003
Do we need HER-2/neu testing for all patients with primary breast carcinoma?Susanne Taucher, Margaretha Rudas, Robert M Mader, et al.
Pageof 9